2023-11-09T12:04:24-06:00 2022-12-31 454084437 WARREN AVERETT LLC 2500 ACTON ROAD BIRMINGHAM AL 35243 990 2022-01-01 630288868 SOUTHERN RESEARCH INSTITUTE SOUT 2055812000 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352555305 DAVID A RUTLEDGE VICE PRESIDENT OF FINANCE 2055812000 2023-11-09 1 DAVID RUTLEDGE XXX-XX-XXXX 0 MEGAN RANDOLPH P00989558 2059794100 2023-11-09 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DAVID A RUTLEDGE 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352555305 179526767 0 X WWW.SOUTHERNRESEARCH.ORG X 1941 AL TO OFFER RESEARCH & TECHNOLOGY SERVICES TO SUPPORT INDUSTRY AND FEDERAL GOVERNMENT AGENCIES. 15 10 453 0 1400007 0 155458 45128927 80785233 52870532 4676470 51621415 37549 30734 85654710 149651608 0 0 0 0 40441997 28685474 0 0 0 36669884 28433399 77111881 57118873 8542829 92532735 124270036 211179645 32180316 30745121 92089720 180434524 X THE INSTITUTE IS ORGANIZED EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL, AND SCIENTIFIC PURPOSES, INCLUDING, MOST PARTICULARLY, THE CARRYING ON OF SCIENTIFIC RESEARCH AND THE DEVELOPMENT AND PROMOTION OF SCIENTIFIC DISCOVERIES, INVENTIONS, AND PROCESSES IN THE PUBLIC INTEREST, AND IS TO BE OPERATED FOR THE BENEFIT OF THE UNIVERSITY OF ALABAMA AT BIRMINGHAM. 0 1 15075610 0 17191464 THE ENGINEERING DIVISION DEVELOPS ENGINEERING SOLUTIONS TO COMPLEX PROBLEMS THROUGH CHARACTERIZING THE MECHANICAL, THERMAL, PHYSICAL, AND CHEMICAL PROPERTIES OF ADVANCED MATERIALS. THE ENGINEERING DIVISION IS ALSO DEVELOPING NEW, LOW-COST PROCESSES TO PRODUCE CARBON/CARBON AND POLYMER MATRIX COMPOSITE MATERIALS AND AEROGELS (ULTRA-LIGHT FOAM), AS WELL AS PROCESSING METHODS TO FABRICATE THESE MATERIALS FOR A WIDE VARIETY OF APPLICATIONS FROM AUTOMOTIVE AND RECREATIONAL PRODUCTS TO THE MOST ADVANCED AEROSPACE APPLICATIONS. SOUTHERN RESEARCH INSTITUTE ALSO PROVIDES ENVIRONMENTAL RESEARCH AND SERVICES TO GOVERNMENT, INDUSTRY, AND PRIVATE INSTITUTIONS. THE RESEARCH HAS LED TO THE DEVELOPMENT OF NEW TEST METHODS AND INSTRUMENTS, THE IMPROVEMENT OF PROCESS AND EMISSION CONTROL TECHNOLOGIES, SOLUTIONS TO DAUNTING NEW ENVIRONMENTAL CHALLENGES, AND OTHER IMPORTANT CONTRIBUTIONS TO ENVIRONMENTAL SCIENCES. 14721930 0 16788145 SCIENTIFIC PLATFORMS HAS ACCOMPLISHED INNOVATIVE RESEARCH IN THE AREAS OF CANCER, INFECTIOUS DISEASE, AND NEUROSCIENCE. WITH A FOCUS ON THE DISCOVERY OF NEW, SMALL-MOLECULE THERAPEUTICS AND THE UNDERSTANDING OF HOW THESE MOLECULES WORK, DRUG DISCOVERY CARRIES OUT TRANSLATIONAL SCIENCE DESIGNED TO INVENT SMALL MOLECULES AND ADVANCE THEM FROM THE DESIGN STAGE TO THE CLINIC. GOVERNMENT FUNDING SUPPORTS OUR EFFORTS IN PIONEERING NEW SCIENTIFIC AREAS OF DRUG DISCOVERY. THE SCIENTIFIC PLATFORMS' STAFF PROVIDES EXPERTISE IN MEDICINAL CHEMISTRY, MOLECULAR BIOLOGY, BIOCHEMISTRY, AND HIGH-THROUGHPUT SCREENING TECHNOLOGIES, ALL FOCUSED ON MAKING DISCOVERIES THAT WILL CONTRIBUTE TO IMPROVING HUMAN HEALTH. THE SCIENTIFIC PLATFORMS' TEAM HAS BEEN VERY EFFECTIVE IN ITS EFFORTS AND HAS DISCOVERED MORE THAN 20 DRUGS THAT HAVE ENTERED CLINICAL TRIALS AND SIX DRUGS THAT HAVE BEEN APPROVED BY THE FDA FOR USE IN THE TREATMENT OF CANCER. 13572470 0 15477359 CRO SERVICES PROVIDES DRUG DISCOVERY AND PRE-CLINICAL DRUG DEVELOPMENT TO PHARMACEUTICAL AND BIOTECHNOLOGY ON AN OUTSOURCED BASIS. SOUTHERN RESEARCH INSTITUTE HAS CAPABILITIES IN ALL PHASES OF THE EARLY-STAGE DRUG DISCOVERY AND DEVELOPMENT PROCESS AND PROVIDES CLIENTS WITH COMPREHENSIVE SERVICES AND SUPPORT TO ASSIST THEM IN STREAMLINING THEIR CUSTOM DRUG DISCOVERY AND DEVELOPMENT PROGRAMS. SOME OF SOUTHERN RESEARCH INSTITUTE'S SIGNIFICANT PRE-CLINICAL RESEARCH ACCOMPLISHMENTS INCLUDE: DEMONSTRATED THE EFFICACY OF COMBINATION CHEMOTHERAPY IN MICE, LEADING THE WAY FOR THE DEVELOPMENT OF THERAPEUTIC APPROACHES WITH IMPROVED CLINICAL OUTCOMES IN CERTAIN CANCERS, PERFORMED PRE-CLINICAL DRUG DEVELOPMENT EVALUATIONS AND ANALYSES ON APPROXIMATELY HALF OF THE FDA-APPROVED CANCER THERAPEUTICS CURRENTLY ON THE MARKET, AND CONTRIBUTED TO THE DEVELOPMENT OF THE FIRST DRUG DELIVERY TECHNOLOGY FOR THE EXTENDED RELEASE OF SYNTHETIC AGENTS THAT PROMOTE THE TREATMENT OF PROSTATE CANCER. 839991 0 957882 SOUTHERN RESEARCH'S STEM EDUCATION OUTREACH PROGRAM IS INVOLVED IN A WIDE VARIETY OF PROGRAMS THAT IMPACT STUDENTS AND TEACHERS IN ALABAMA. THE MISSION OF SR'S STEM PROGRAM IS TO ENHANCE 6TH 12TH GRADE STEM EDUCATION BY DRAWING UPON THE EXPERTISE AND SCHOLARLY CONTRIBUTIONS OF THE SOUTHERN RESEARCH COMMUNITY. WE AIM TO DEFINE AND EXEMPLIFY EFFECTIVE STEM EDUCATION TO MAXIMIZE STUDENTS' READINESS TO EXCEL IN A RAPIDLY CHANGING WORLD. WE ARE WORKING TO ACHIEVE OUR EDUCATION MISSION BY ENGAGING STUDENTS AND TEACHERS IN STEM ACTIVITIES THROUGH SUMMER LEARNING PROGRAMS, FIELD TRIPS, AFTER-SCHOOL PROGRAMING, STEM COMPETITIONS AND SCIENCE FAIRS, INTERNSHIPS, AND PROFESSIONAL DEVELOPMENT WORKSHOPS FOR STEM EDUCATORS. OUR PRIMARY OBJECTIVE IS TO EMBOLDEN STUDENTS WHO POSSESS A PASSION FOR INNOVATION AND DISCOVERY TO PURSUE THEIR INTERESTS AND STRENGTHEN THE STEM COMMUNITY. SOUTHERN RESEARCH IS COMMITTED TO FOSTERING CREATIVITY AND IMPACTING THE FUTURE GENERATION. 839991 0 957882 44210001 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 177 0 1 453 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 15 10 0 0 1 0 0 1 1 1 1 0 0 1 1 1 1 1 0 1 1 0 X DAVID A RUTLEDGE 2055812000 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352555305 CHRISTOPHER S BROWN PHD DIRECTOR 1.00 40.00 X 0 400794 82288 CHARLES K PORTER THROUGH 222 DIRECTOR 1.00 0.00 X 0 0 0 RAY WATTS CHAIRMAN 1.00 40.00 X 0 674603 79409 MARK CROSSWHITE DIRECTOR 1.00 0.00 X 0 0 0 GENE RUFFNER PAGE JR VICE CHAIRMAN 1.00 0.00 X 0 0 0 FINIS ST JOHN VI DIRECTOR 1.00 40.00 X 0 1180431 136397 JAMEY MCMAHON DIRECTOR 1.00 0.00 X 0 0 0 REGINA BENJAMIN MD SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 LEE STYLINGER III SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 SCOTT PHELPS SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 KEN SIMON SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 MIKE BROCK SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 KNIGHT BOBBIE SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 NEEL VARSHNEY MD SINCE 422 DIRECTOR 1.00 0.00 X 0 0 0 ANUPAM AGARWAL MD SINCE 822 DIRECTOR 1.00 40.00 X 0 223794 49713 JEANNE MARAZZO MD SINCE 422 DIRECTOR 1.00 40.00 X 0 232968 47977 M SELWYN VICKERS MD 422-722 DIRECTOR 1.00 40.00 X 0 297958 44528 MICHAEL D JOHNS THROUGH 522 VP ENGINEERING 40.00 0.00 X 150328 0 16241 G ALLEN BOLTON JR THROUGH 522 VP, STRATEGY & FINANCE 1.00 40.00 X 146465 0 14729 CE AUGELLI-SZAFRAN VP, SCIENTIFIC PLATFORM 40.00 0.00 X 272003 0 15763 DAVID A RUTLEDGE VP OF FINANCE 40.00 2.00 X 247567 0 22797 JOSHUA D CARPENTER CHIEF EXECUTIVE OFFICER 40.00 0.00 X 373706 0 17373 KEVIN W BURTON VP RESEARCH SERVICES 40.00 0.00 X 244450 0 19154 AVANTI PAUL VP OPERATIONS 40.00 0.00 X 139231 0 18767 ANNA BRANTLEY FRY VP OF PEOPLE & COMMUNITY 40.00 0.00 X 207560 0 23806 ABISHEK KULSHRESHTHA CHIEF OF STAFF 40.00 0.00 X 153418 0 7594 SUBASH DAS DIRECTOR OF INFECTIOUS DISEASE RESEARCH 40.00 0.00 X 194079 0 19198 MICHAEL E HUDSON PHARMACEUTICAL CONSULTANT 40.00 0.00 X 204051 0 21515 ALIREZA MORADI DIRECTOR, FACILITIES & SECURITY 40.00 0.00 X 200881 0 0 BABU L TEKWANI INFECTIOUS DISEASES CHAIR 40.00 0.00 X 211774 0 17371 FUSATAKA KOIDE DIRECTOR OF VIROLOGY 40.00 0.00 X 230292 0 22405 2975805 3010548 677025 48 0 1 0 BALLARD SPAHR LLP 999 PEACHTREE STREET NE SUITE 1600 ATLANTA GA 30309 LEGAL 561379 BRASFIELD & GORRIE LLC 3021 7TH AVE S BIRMINGHAM AL 35233 CONSTRUCTION AND ENGINEERING 523573 WILLIAMS BLACKSTOCK ARCHITECTS 2204 1ST AVE S SUITE 200 BIRMINGHAM AL 35233 ARCHITECHTURE 472213 JACKSON BOND ENTERPRISES LLC 39 INDUSTRIAL PARK DRIVE DOVER NH 03820 ENGINEERING 417780 WARREN AVERETT LLC 2500 ACTON ROAD 200 BIRMINGHAM AL 35243 ACCOUNTING 261861 12 45000000 128927 45128927 RESEARCH CONTRACTS 541710 51814857 50414850 1400007 INTELLECTUAL PROPERTY REVENUE 541900 1055675 1055675 52870532 1450669 1450669 76639 45905 30734 30734 30734 80000000 29829254 50170746 50170746 50170746 149651608 50414850 1400007 52707824 X 1934727 1497479 437248 18833177 14576879 4256298 7917570 6128199 1789371 118842 91984 26858 389730 301651 88079 150715 116653 34062 7877997 6097569 1780428 375972 291002 84970 5267981 4077417 1190564 1934035 1496943 437092 559608 433137 126471 261599 202478 59121 3843332 2974739 868593 1182569 915308 267261 OTHER DIRECT COSTS 3477663 2691706 785957 EQUIPMENT MAINTENANCE 1771339 1371016 400323 DIRECT ANIMAL CARE 500288 387223 113065 DUES & SUBSCRIPTIONS 289880 224367 65513 431849 334251 97598 57118873 44210001 12908872 0 2218692 3436195 15201 3294 20639167 11099935 920111 216277 814499 791055 87208587 66781306 30344063 20427281 63878732 166414732 593910 3813052 2103141 1808088 2742520 3169736 124270036 211179645 6880456 8046945 9710441 9656534 13628883 9576901 1960536 3464741 32180316 30745121 X 0 0 18818321 12658468 73271399 167776056 92089720 180434524 124270036 211179645 92532735 -4187931 0 X X 0 1 X 1 1 1 X 1874584 1696657 270253 160958 128927 4131379 62559208 71203397 78155531 76088020 50414850 338421006 43422 47135 1461 8449 0 100467 64477214 72947189 78427245 76257427 50543777 342652852 0 0 0 342652852 1264735 630116 388345 492581 1450669 4226446 3595201 5404457 3916594 4697213 1400007 19013472 4859936 6034573 4304939 5189794 2850676 23239918 69337150 78981762 82732184 81447221 53394453 365892770 0.93650 0.93170 0.06350 0.06830 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 0 0 1 148147 0 1 148147 0 PART II-B, LINE 1: DURING THE YEAR, SRI CONTRACTED WITH A THIRD-PARTY GOVERNMENT RELATIONS AND LOBBYING FIRM THAT CONDUCTED OUR GOVERNMENTAL AFFAIRS WHICH INCLUDED REPRESENTING OUR INTERESTS WITH REGULATORY, LEGISLATIVE, AND EXECUTIVE BODIES AND AGENCIES, OFFERING REGISTERED LOBBYING SERVICES TO PROMOTE SRI'S MISSION AND KEY INITIATIVES WITH THE ABOVE, AND ASSISTING THE ORGANIZATION WITH A BETTER UNDERSTANDING OF THE CHANGES AND DEVELOPMENTS IN THE REGULATORY AND LEGISLATIVE ENVIRONMENTS IN WHICH WE OPERATE. TOTAL PAYMENTS TO THE FIRM MENTIONED ABOVE WERE $93,337 AND OUR INTERNAL COSTS ASSOCIATED WITH THESE ACTIVITIES WERE $54,810, TOTALING $148,147 IN 2022. 0 13308476 -1241720 573373 22133 11471250 12226041 1670896 557524 30937 13308476 11933466 880109 559151 28383 12226041 10721291 1803175 558088 32912 11933466 12077419 -774465 552791 28872 10721291 0.00000 0.00000 1.00000 0 0 2918352 2918352 34602876 31199824 3403052 1119340 1119340 0 44035109 34462142 9572967 4532910 4532910 20427281 POST RETIRMENT BENEFITS 1824877 LINE OF CREDIT 1639864 3464741 145329903 -4187931 45905 -4142026 149471929 179679 179679 149651608 56985099 45905 45905 56939194 179679 179679 57118873 PART V, LINE 4: THE INTENDED USE OF THE FUNDS IS TO HELP CERTAIN OUTSTANDING NEWLY-HIRED SCIENTISTS GET THEIR LABORATORIES ESTABLISHED BEFORE THEY HAVE SECURED FUNDING FROM OUTSIDE SPONSORS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS OFFSET TO REVENUE ON THE RETURN 45,905. PART XI, LINE 4B - OTHER ADJUSTMENTS: INCOME SHOWN AS REDUCTION TO EXPENSES ON BOOKS 28,964. INVESTMENT EXPENSES SHOWN AS OFFSET TO INCOME ON BOOKS 150,715. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS OFFSET TO REVENUE ON THE RETURN 45,905. PART XII, LINE 4B - OTHER ADJUSTMENTS: INCOME INCLUDED AS REDUCTION TO EXPENSES ON BOOKS 28,964. INVESTMENT EXPENSES SHOWN AS OFFSET TO INCOME ON BOOKS 150,715. X 1 1 X X 0 1 0 0 0 0 0 0 0 FINIS ST JOHN VI DIRECTOR 0 747170 0 318266 0 114995 0 124636 0 12607 0 1317674 0 0 RAY WATTS CHAIRMAN 0 533596 0 132930 0 8077 0 79409 0 2782 0 756794 0 0 CHRISTOPHER S BROWN PHD DIRECTOR 0 381309 0 13030 0 6455 0 75708 0 8586 0 485088 0 0 JOSHUA D CARPENTER CHIEF EXECUTIVE OFFICER 346741 0 0 0 26965 0 0 0 17373 0 391079 0 0 0 M SELWYN VICKERS MD 422-722 DIRECTOR 0 287498 0 7627 0 2833 0 44528 0 1499 0 343985 0 0 CE AUGELLI-SZAFRAN VP, SCIENTIFIC PLATFORM 266095 0 4080 0 1828 0 0 0 15763 0 287766 0 0 0 JEANNE MARAZZO MD SINCE 422 DIRECTOR 0 229999 0 2969 0 0 0 38647 0 10375 0 281990 0 0 ANUPAM AGARWAL MD SINCE 822 DIRECTOR 0 220915 0 2879 0 0 0 49713 0 1157 0 274664 0 0 DAVID A RUTLEDGE VP OF FINANCE 234566 0 1000 0 12001 0 0 0 22797 0 270364 0 0 0 KEVIN W BURTON VP RESEARCH SERVICES 222858 0 0 0 21592 0 0 0 19154 0 263604 0 0 0 FUSATAKA KOIDE DIRECTOR OF VIROLOGY 136906 0 65749 0 27637 0 0 0 22405 0 252697 0 0 0 ANNA BRANTLEY FRY VP OF PEOPLE & COMMUNITY 198383 0 155 0 9022 0 0 0 23806 0 231366 0 0 0 BABU L TEKWANI INFECTIOUS DISEASES CHAIR 167590 0 14170 0 30014 0 0 0 17371 0 229145 0 0 0 MICHAEL E HUDSON PHARMACEUTICAL CONSULTANT 198045 0 0 0 6006 0 0 0 21515 0 225566 0 0 0 SUBASH DAS DIRECTOR OF INFECTIOUS DISEASE RESEA 165888 0 0 0 28191 0 0 0 19198 0 213277 0 0 0 ALIREZA MORADI DIRECTOR, FACILITIES & SECURITY 172054 0 0 0 28827 0 0 0 0 0 200881 0 0 0 MICHAEL D JOHNS THROUGH 522 VP ENGINEERING 105393 0 0 0 44935 0 0 0 16241 0 166569 0 0 0 G ALLEN BOLTON JR THROUGH 522 VP, STRATEGY & FINANCE 124542 0 0 0 21923 0 0 0 14729 0 161194 0 0 0 ABISHEK KULSHRESHTHA CHIEF OF STAFF 145504 0 0 0 7914 0 0 0 7594 0 161012 0 0 0 AVANTI PAUL VP OPERATIONS 121180 0 155 0 17896 0 0 0 18767 0 157998 0 0 0 PART I, LINE 4B RAY WATTS - $79,409 G. ALLEN BOLTON, JR - $124,636 CHRISTOPHER S. BROWN - $75,708 ANUPAM AGARWAL, MD - $49,713 JEANNE MARAZZO, MD - $38,647 A THE COOPERATIVE DISTRICT OF THE CITY OF BIRMINGHAM-SOUTHERN RESEARCH INST 273338884 NONEAVAIL 2010-08-31 20000000 SOUTHSIDE AND OXMOOR CAMPUS CAPITAL IMPROVEMENTS 0 1 0 A 10501487 20000000 174000 19826000 2014 0 0 1 1 A 0 1 0 1 1 0 1 0.01200 0 1 A 0 1 0 0 0 0 0 0 1 A 1 SCHEDULE K, PART III, LINES 2, 3(C), 4, 5, 6, 7, 8(A), 8(B), 8(C) THE ORGANIZATION'S OUTSTANDING BONDS WERE ISSUED AS "RECOVERY ZONE FACILITY BONDS" UNDER SECTION 1400U-1(B) OF THE INTERNAL REVENUE CODE. THE OUTSTANDING BONDS ARE CONSIDERED PRIVATE ACTIVITY BONDS AND THEREFORE PRIVATE BUSINESS USE AND PRIVATE PAYMENT AND SECURITY ARE NOT RELEVANT TO SUCH BONDS. SCHEDULE K, PART III, LINE 9, PART IV, LINE 7 AND PART V: THE ORGANIZATION BY ACTION OF ITS FINANCE COMMITTEE OF ITS BOARD OF DIRECTORS ON OCTOBER 30, 2014, ESTABLISHED WRITTEN PROCEDURES. SCHEDULE K, PART IV, LINES 3, 4(A), 4(B), 4(C), 4(D), AND 4(E): AS OF 9/22/2017, THE BOND ISSUE WAS CONVERTED FROM A VARIABLE RATE TO A FIXED RATE. DURING THE VARIABLE RATE PERIOD, THE ORGANIZATION ENTERED INTO A QUALIFIED HEDGE WITH RESPECT TO THE BOND ISSUE WITH BBVA COMPASS, WITH A TERM OF 6.0 YEARS. SUCH HEDGE TERMINATED BY ITS TERMS ON 9/1/2017. FORM 990, PART III, LINE 3 ON MAY 23, 2022, THE ORGANIZATION SOLD THE ASSETS AND LIABILITIES COMPRISING ITS ENGINEERING DIVISION TO KRATOS DEFENSE & SECURITY SOLUTIONS. FORM 990, PART VI, SECTION A, LINE 4 AS OF THE ADOPTION OF THE THIRD AMENDED AND RESTATED CHARTER ON MAY 24, 2022, THE MAXIMUM NUMBER OF MEMBERS ON THE BOARD OF DIRECTORS WAS INCREASED FROM NINE (9) TO FIFTEEN (15). FORM 990, PART VI, SECTION A, LINE 7A THE DIRECTORS SHALL BE APPOINTED BY THE PRESIDENT OF THE UNIVERSITY OF ALABAMA AT BIRMINGHAM, A RELATED GOVERNMENTAL ENTITY, PROVIDED SUCH APPOINTMENT IS APPROVED BY THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA. FORM 990, PART VI, SECTION A, LINE 7B THE GOVERNING DOCUMENTS STATE THAT THE ORGANIZATION MAY NOT ADOPT A PLAN OF MERGER, CONSOLIDATION OR DISSOLULTION AND CANNOT SELL, LEASE, EXCHANGE, MORTGAGE, PLEDGE OR OTHERWISE DISPOSE OF ALL OR SUBSTANTIALLY ALL OF THE ORGANIZATION'S ASSETS WITHOUT APPROVAL FROM THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA. FURTHERMORE, THE GOVERNING DOCUMENTS MAY NOT BE AMENDED WITHOUT PRIOR CONSENST FROM THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS HAS ADOPTED THE POLICY THAT THE FINANCE COMMITTEE WOULD REVIEW AND APPROVE THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS, DIRECTORS, AND KEY/HIGHLY COMPENSATED EMPLOYEES ARE REQUIRED TO DISCLOSE ANNUALLY ANY POTENTIAL CONFLICTS OF INTEREST OR CERTIFY THAT NO SUCH CONFLICTS EXIST. THE ORGANIZATION INVESTIGATES DISCLOSURES OF ANY POTENTIAL CONFLICTS AND TAKES STEPS TO MITIGATE THE OCCURRENCE OF ACTUAL CONFLICTS OF INTEREST. SHOULD A CONFLICT OF INTEREST OCCUR, THE OFFICER, DIRECTOR, AND KEY/HIGHLY COMPENSATED EMPLOYEE WILL BE EXCUSED FROM VOTING ON MATTERS ASSOCIATED WITH THE ENTITY THAT THE CONFLICT OF INTEREST AROSE WITH. FORM 990, PART VI, SECTION B, LINE 15 A REVIEW OF COMPENSATION FOR THE EXECUTIVE TEAM WAS COMPLETED DURING THE FIRST QUARTER OF 2021 BY THE WILSON GROUP, AN EXTERNAL COMPENSATION CONSULTING FIRM. THIS REVIEW IS UNDERTAKEN EVERY TWO YEARS. COMPENSATION OF THE ORGANIZATION'S CEO AND OTHER LEADERSHIP POSITIONS WERE REVIEWED AT THAT TIME. FORM 990, PART VI, SECTION C, LINE 19 AS A GENERAL RULE, THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. ANY WRITTEN REQUEST BY THE PUBLIC WOULD BE REVIEWED AND ACTED UPON BY THE BOARD. FORM 990, PART IX, LINE 11G OUTSIDE SERVICES: PROGRAM SERVICE EXPENSES 2,757,322. MANAGEMENT AND GENERAL EXPENSES 805,110. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 3,562,432. CONSULTANTS: PROGRAM SERVICE EXPENSES 3,318,594. MANAGEMENT AND GENERAL EXPENSES 968,995. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 4,287,589. OTHER PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 21,653. MANAGEMENT AND GENERAL EXPENSES 6,323. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 27,976. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE OF THE ORGANIZATION ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. UNIVERSITY OF ALABAMA AT BIRMINGHAM 1530 THIRD AVENUE SOUTH BIRMINGHAM AL 352941150 636005396 HIGHER EDUCATON FACILITY AL POLITICAL SUBDVISION N/A 0 SOUTHERN RESEARCH INSTITUTE VEBA 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 35205 562439567 VOLUNTARY EMPLOYEE BENEFIT ASSOCIATION AL 501(C)(9) SOUTHERN RESEARCH INSTITUTE 1 THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 500 UNIVERSITY BLVD EAST TUSCALOOSA AL 35401 636001138 HIGHER EDUCATON FACILITY AL 501(C)(3) N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0